Hepatotoxicity of combined therapy with rifampicin and daily prothionamide for leprosy.
D000328:Adult; D000368:Aged; D056486:Chemical and Drug Induced Liver Injury / Q000209:etiology*; D002681:China; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D007539:Isonicotinic Acids / Q000009:adverse effects*; D007918:Leprosy / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D011515:Prothionamide / Q000009:adverse effects* / Q000627:therapeutic use; D012293:Rifampin / Q000009:adverse effects* / Q000627:therapeutic use
D007539:Isonicotinic Acids; D011515:Prothionamide; D012293:Rifampin